EX-10.39

BORROWERS:

KEYSTONE DENTAL, INC.

Amnon Tamir

Exhibit 10.39

Execution Version

AMENDMENT NO. 1 TO CREDIT, SECURITY AND GUARANTY AGREEMENT (REVOLVING LOAN)

This AMENDMENT NO. 1 TO CREDIT, SECURITY AND GUARANTY AGREEMENT (REVOLVING LOAN) (this “Agreement”) is made as of January 24, 2023, by and among KEYSTONE DENTAL, INC. (the “Borrower”), KEYSTONE DENTAL HOLDINGS, INC. (“Holdings”), IMPLANT SOLUTIONS PTY LTD., PALTOP ADVANCED DENTAL SOLUTIONS LTD., IOS INNOVATIONS PTY LTD (each individually as a “Guarantor”, and collectively, the “Guarantors”), MIDCAP FUNDING IV TRUST, a Delaware statutory trust, as Agent (in such capacity, together with its successors and assigns, “Agent”) and the other financial institutions or other entities from time to time parties to the Credit Agreement referenced below, each as a Lender.

RECITALS

A. Agent, Lenders, and the Credit Parties have entered into that certain Credit, Security and Guaranty Agreement (Revolving Loan), dated as of June 7, 2022 (the “Original Credit Agreement” and as amended hereby and as it may be further amended, modified, supplemented and restated from time to time, the “Credit Agreement”), pursuant to which the Lenders have agreed to make certain advances of money and to extend certain financial accommodations to Borrowers in the amounts and manner set forth in the Credit Agreement.

B. The Credit Parties have requested, and Agent and all Lenders have agreed, to amend certain provisions of the Original Credit Agreement to, among other things, amend the Floor, certain provisions regarding the Deferred Revolving Loan Origination Fee and certain provisions regarding the Lockbox Account, in accordance with the terms and subject to the conditions set forth herein.

AGREEMENT

NOW, THEREFORE, in consideration of the foregoing, the terms and conditions set forth in this Agreement, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Agent, Lenders and the Credit Parties hereby agree as follows:

1. Recitals. This Agreement shall constitute a Financing Document and the Recitals and each reference to the Credit Agreement, unless otherwise expressly noted, will be deemed to reference the Credit Agreement as amended hereby. The Recitals set forth above shall be construed as part of this Agreement as if set forth fully in the body of this Agreement and capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Credit Agreement (including those capitalized terms used in the Recitals hereto).

2. Amendments to Original Credit Agreement. Subject to the terms and conditions of this Agreement, including, without limitation, the conditions to effectiveness set forth in Section 4 below, the Original Credit Agreement is hereby amended as follows:

(a) Section 1.1 of the Original Credit Agreement is hereby amended by adding the following definitions in alphabetical order therein:

“First Amendment” shall mean that certain Amendment No. 1 to Credit, Security and Guaranty Agreement (Revolving Loan), dated as of the First Amendment Effective Date, by and among the Credit Parties, Agent and the Lenders.

“First Amendment Effective Date” shall mean January 24, 2023.

MidCap / Keystone / Amendment No. 1 to Credit Agreement (Revolving Loan)

“Lockbox Transition Period” has the meaning ascribed to such term in Section 2.11(b).

(b) Section 1.1 of the Original Credit Agreement is hereby amended by amending and restating the definitions of “Base Rate”, and “Floor”, respectively, as follows:

“Base Rate” means a per annum rate of interest equal to the greater of (a) two and one half percent (2.50%) per annum and (b) a per annum rate of interest equal to the rate of interest announced, from time to time, within Wells Fargo Bank, National Association (“Wells Fargo”) at its principal office in San Francisco as its “prime rate,” with the understanding that the “prime rate” is one of Wells Fargo’s base rates (not necessarily the lowest of such rates) and serves as the basis upon which effective rates of interest are calculated for those loans making reference thereto and is evidenced by the recording thereof after its announcement in such internal publications as Wells Fargo may designate; provided, however, that Agent may, upon prior written notice to Borrower, choose a reasonably comparable index or source to use as the basis for the Base Rate.

“Floor” means the rate per annum of interest equal to 2.50%.

“(g) Deferred Revolving Loan Origination Fee. If Lenders’ funding obligations in respect of the Revolving Loan Commitment under this Agreement terminate or are permanently reduced for any reason (whether by voluntary termination by Borrowers, by reason of the occurrence of an Event of Default or the automatic termination of the Revolving Loan Commitments (including any automatic termination due to the occurrence of an Event of Default described in Section 10.1(f)) or otherwise) prior to the Maturity Date, Borrowers shall pay to Agent on the date of such reduction, for the benefit of all Lenders committed to make Revolving Loans on the Closing Date, a fee as compensation for the costs of such Lenders being prepared to make funds available to Borrowers under this Agreement, equal to an amount determined by multiplying the amount of the Revolving Loan Commitment so terminated or permanently reduced by the following applicable percentage amount: (x) three percent (3.00%) for the first year following the First Amendment Effective Date, (y) two percent (2.00%) for the second year following the First Amendment Effective Date, and (z) and one percent (1.00%) thereafter. All fees payable pursuant to this paragraph shall be deemed fully-earned on of the Closing Date and non-refundable once paid.”

(d) Section 2.11(a) of the Original Credit Agreement is hereby amended and restated as follows:

“(a) By the date that is five (5) Business Days prior to the initial borrowing of the Revolving Loans (or such later date as Agent may agree in writing) (the “Lockbox Activation Date”), a lockbox (the “Lockbox”) and a Lockbox Account with a United States depository institution reasonably acceptable to Agent (the “Lockbox Bank”), subject to the provisions of this Agreement, and shall execute with the Lockbox Bank a Deposit Account Control Agreement and such other agreements related to such Lockbox and/or Lockbox Account as Agent may require. At all times following the Lockbox Transition Period, Borrowers shall ensure that all collections of Accounts are paid directly from Account Debtors (i) into the Lockbox for deposit into the Lockbox Account and/or (ii) directly into the Lockbox Account; provided, however, that unless Agent shall otherwise direct by written notice to Borrowers, Borrowers shall be permitted to cause

MidCap / Keystone / Amendment No. 1 to Credit Agreement (Revolving Loan)

Account Debtors who are individuals to pay Accounts directly to Borrowers, which Borrowers shall then administer and apply in the manner required below. All funds deposited into a Lockbox Account after the Lockbox Activation Date shall be transferred into the Payment Account (or, prior to the time of the initial borrowing of the Revolving Loans, such Deposit Account of Borrower as Agent may direct in its sole discretion) by the close of each Business Day. At all times during the Lockbox Transition Period, Borrower shall ensure that, by the close of business on Friday of each calendar week (commencing with the first full calendar week after the First Amendment Effective Date), all collections received by or on behalf of Borrowers in respect of Accounts prior to such Friday are transferred, pursuant to an irrevocable standing wire instruction, into a Lockbox Account that is subject to a Deposit Account Control Agreement.”

(e) Section 2.11(b) of the Original Credit Agreement is hereby amended and restated as follows:

“(b) By the date that is ninety (90) days after the Lockbox Activation Date (or such later date as Agent may agree in writing) (such period, the “Lockbox Transition Period”), Borrower shall ensure that all Account Debtors are instructed to pay, and all collections are paid, directly into the Lockbox for deposit into the Lockbox Account and/or directly into the Lockbox Account.”

(f) Article 4 of the Original Credit Agreement is hereby amended to add the following new Section 4.19 immediately following the end of Section 4.18 therein:

“Section 4.19 Board Observer Rights. Agent and/or its designees (including any Lender) shall have the right, on behalf of itself and/or the other Lenders, to: (a) receive notice of all meetings (both regular and special) of the board of directors (or other comparable body) and/or the equity holders of each Credit Party, and each committee of any such board of directors (or other comparable body) (such notice to be delivered or mailed to Agent as specified in this Agreement at the same time as notice is given to the members of any such board of directors (or other comparable body) and/or committee and/or equity holders) but in no event later than two (2) Business Days prior to the date of such meeting; (b) be entitled to attend all such meetings (telephonically or in person, at Agent’s or its designee’s discretion) in a nonvoting capacity; (c) receive all notices, information, reports and minutes of meetings, which are furnished (or made available) to the members of any such board of directors (or other comparable body) and/or committee and/or equity holders at the same time and in the same manner as the same is furnished (or made available) to such members, and (d) be entitled to participate in all discussions conducted at such meetings. If any action is proposed to be taken by any such board of directors (or other comparable body) and/or committee by written consent in lieu of a meeting, the applicable Credit Party shall provide written notice thereof to the Agent or its applicable designees, which notice shall describe in reasonable detail the nature and substance of such proposed action and shall be delivered not later than the date upon which any member of any such board of directors (or other comparable body) and/or committee receives the same. Each Credit Party shall provide the Agent or its applicable designees with a copy of each such written consent not later than five (5) Business Days after it has been signed by a sufficient number of signatories to make it effective. Agent or, as applicable, Agent’s designees shall not constitute a member of any such board of directors (or other comparable body) and/or committee and shall not be entitled to vote on any matters presented at meetings of any such board of directors (or other comparable body) and/or committee or to consent to any matter as to which the consent of any such board of directors (or other comparable body) and/or committee shall have been requested. Each Credit Party shall reimburse the Agent

MidCap / Keystone / Amendment No. 1 to Credit Agreement (Revolving Loan)

and/or its designees, as applicable, for all reasonable out-of-pocket expenses incurred in connection with attending such meetings and/or exercising any rights under this Section 4.19. Notwithstanding the foregoing, Agent, and or its designee may be excluded from receiving any such information and materials (or the relevant portions thereof) or from attending such meetings (or the relevant portions thereof) pursuant to this Section 4.19 to avoid a conflict of interest, to protect attorney-client privilege or with respect to highly confidential information of third parties; provided that, for the avoidance of doubt, in all cases Credit Parties shall still be required to notify Agent of all meetings under clause (a) above regardless of whether Agent and/or its designees are excluded from such meeting or portion of such meeting and provide Agent (together with such notice) the criteria pursuant to which Agent and/or its designees are being excluded from such meeting.”

3. Representations and Warranties; Reaffirmation of Security Interest. Each Credit Party hereby confirms that all of the representations and warranties set forth in the Credit Agreement are true and correct in all material respects (without duplication of any materiality qualifier in the text of such representation or warranty) with respect to such Credit Party as of the date hereof except to the extent that any such representation or warranty relates to a specific date in which case such representation or warranty shall be true and correct as of such earlier date. Each Credit Party reaffirms its obligations under each Security Document, including each Australian Security Agreement and each Israeli Security Document, to which it is a party, and confirms and agrees that all security interests and Liens granted to the Agent continue in full force and effect, and all Collateral remains free and clear of any Liens, other than Permitted Liens. Nothing herein is intended to impair or limit the validity, priority or extent of Agent’s security interests in and Liens on the Collateral. Each Credit Party acknowledges and agrees that the Credit Agreement, the other Financing Documents and this Agreement constitute the legal, valid and binding obligation of such Credit Party, and are enforceable against such Credit Party in accordance with its terms, except as the enforceability thereof may be limited by bankruptcy, insolvency or other similar laws relating to the enforcement of creditors’ rights generally and by general equitable principles.

4. Conditions to Effectiveness. This Agreement shall become effective as of the date on which each of the following conditions have been satisfied, as determined by Agent in its reasonable discretion:

(a) Agent shall have received (including by way electronic transmission) a duly authorized, executed and delivered counterpart of the signature page to this Agreement from each Credit Party, Agent and the Lenders;

(b) Agent shall have received a duly executed copy of Amendment No. 1 to Credit, Security and Guaranty Agreement (Term Loan), dated as of the date hereof, in respect of the Affiliated Credit Agreement;

(c) Agent shall have received from the Credit Parties updated versions of Schedule 3.19, Schedule 5.14, Schedule 9.2(b) and Schedule 9.2(d), in form and substance reasonably satisfactory to Agent, in each case, correcting all outdated, inaccurate, incomplete or misleading information;

(d) Agent shall have received from the Credit Parties all of the fees due on the First Amendment Effective Date pursuant to the Credit Agreement;

(e) all representations and warranties of Credit Parties contained herein shall be true and correct in all material respects (without duplication of any materiality qualifier in the text of such representation or warranty) as of the date hereof except to the extent that any such representation or warranty relates to a specific date in which case such representation or warranty shall be true and correct as of such earlier date (and such parties’ delivery of their respective signatures hereto shall be deemed to be its certification thereof); and

MidCap / Keystone / Amendment No. 1 to Credit Agreement (Revolving Loan)

(f) prior to and after giving effect to the agreements set forth herein, no Default or Event of Default shall exist under any of the Financing Documents.

5. Costs and Fees. Borrowers agree to promptly pay, or reimburse promptly following demand for, all reasonable and documented costs and expenses of Agent (including, without limitation, the reasonable and documented fees, costs and expenses of counsel to Agent) in connection with the preparation, negotiation, execution and delivery of this Agreement and any other Financing Documents or other agreements prepared, negotiated, executed or delivered in connection with this Agreement or transactions contemplated hereby, subject to and in accordance with Section 13.14 of the Credit Agreement.

6. Release. In consideration of the agreements of Agent and Lenders contained herein and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, Credit Party, voluntarily, knowingly, unconditionally and irrevocably, with specific and express intent, for and on behalf of itself and all of its respective parents, subsidiaries, affiliates, members, managers, predecessors, successors, and assigns, and each of their respective current and former directors, officers, shareholders, agents, and employees, and each of their respective predecessors, successors, heirs, and assigns (individually and collectively, the “Releasing Parties”) does hereby fully and completely release, acquit and forever discharge each of Agent, Lenders, and each their respective parents, subsidiaries, affiliates, members, managers, shareholders, directors, officers and employees, and each of their respective predecessors, successors, heirs, and assigns (individually and collectively, the “Released Parties”), of and from any and all actions, causes of action, suits, debts, disputes, damages, claims, obligations, liabilities, costs, expenses and demands of any kind whatsoever, at law or in equity, whether matured or unmatured, liquidated or unliquidated, vested or contingent, choate or inchoate, known or unknown that the Releasing Parties (or any of them) has against the Released Parties or any of them (whether directly or indirectly). Each Credit Party acknowledges that the foregoing release is a material inducement to Agent’s and each Lender’s decision to enter into this Agreement and agree to the modifications contemplated hereunder, and has been relied upon by Agent and Lenders in connection therewith.

7. No Waiver or Novation. The execution, delivery and effectiveness of this Agreement shall not, except as expressly provided in this Agreement, operate as a waiver of any right, power or remedy of Agent, nor constitute a waiver of any provision of the Credit Agreement, the Financing Documents or any other documents, instruments and agreements executed or delivered in connection with any of the foregoing. Nothing herein is intended or shall be construed as a waiver of any existing Defaults or Events of Default under the Credit Agreement or the other Financing Documents or any of Agent’s rights and remedies in respect of such Defaults or Events of Default. This Agreement (together with any other document executed in connection herewith) is not intended to be, nor shall it be construed as, a novation of the Credit Agreement.

8. Affirmation. Except as specifically amended pursuant to the terms hereof, each Credit Party hereby acknowledges and agrees that the Credit Agreement and all other Financing Documents (and all covenants, terms, conditions and agreements therein) shall remain in full force and effect, and are hereby ratified and confirmed in all respects by such Credit Party. Each Credit Party covenants and agrees to comply with all of the terms, covenants and conditions of the Credit Agreement and the Financing Documents, notwithstanding any prior course of conduct, waivers, releases or other actions or inactions on Agent’s or any Lender’s part which might otherwise constitute or be construed as a waiver of or amendment to such terms, covenants and conditions.

MidCap / Keystone / Amendment No. 1 to Credit Agreement (Revolving Loan)

9. Miscellaneous.

(a) Reference to the Effect on the Credit Agreement. Upon the effectiveness of this Agreement, each reference in the Credit Agreement to “this Agreement,” “hereunder,” “hereof,” “herein,” or words of similar import shall mean and be a reference to the Credit Agreement, as amended by this Agreement. Except as specifically amended above, the Credit Agreement, and all other Financing Documents (and all covenants, terms, conditions and agreements therein), shall remain in full force and effect, and are hereby ratified and confirmed in all respects by each Credit Party.

(b) Governing Law. THIS AGREEMENT AND ALL DISPUTES AND OTHER MATTERS RELATING HERETO OR ARISING THEREFROM (WHETHER SOUNDING IN CONTRACT LAW, TORT LAW OR OTHERWISE), SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO CONFLICTS OF LAWS PRINCIPLES (OTHER THAN SECTION 5-1401 OF THE GENERAL OBLIGATIONS LAW).

(c) Incorporation of Credit Agreement Provisions. The provisions contained in Section 11.6 (Indemnification), Section 13.8(b) (Submission to Jurisdiction) and Section 13.9 (Waiver of Jury Trial) of the Credit Agreement are incorporated herein by reference to the same extent as if reproduced herein in their entirety.

(d) Headings. Section headings in this Agreement are included for convenience of reference only and shall not constitute a part of this Agreement for any other purpose.

(e) Counterparts. This Agreement may be signed in any number of counterparts, each of which shall be deemed an original and all of which when taken together shall constitute one and the same instrument. Signatures by facsimile or by electronic mail delivery of an electronic version of any executed signature page shall bind the parties hereto.

(f) Entire Agreement. This Agreement constitutes the entire agreement and understanding among the parties hereto and supersedes any and all prior agreements and understandings, oral or written, relating to the subject matter hereof.

(g) Severability. In case any provision of or obligation under this Agreement shall be invalid, illegal or unenforceable in any applicable jurisdiction, the validity, legality and enforceability of the remaining provisions or obligations, or of such provision or obligation in any other jurisdiction, shall not in any way be affected or impaired thereby.

(h) Successors/Assigns. This Agreement shall bind, and the rights hereunder shall inure to, the respective successors and assigns of the parties hereto, subject to the provisions of the Credit Agreement and the other Financing Documents.

[SIGNATURES APPEAR ON FOLLOWING PAGES]

MidCap / Keystone / Amendment No. 1 to Credit Agreement (Revolving Loan)

IN WITNESS WHEREOF, intending to be legally bound, and intending that this document constitute an agreement executed under seal, the undersigned have executed this Agreement under seal as of the day and year first hereinabove set forth.


AGENT:	MIDCAP FUNDING IV TRUST,
	as Agent

	By:	Apollo Capital Management, L.P.,
	its investment manager

	By:	Apollo Capital Management GP, LLC,
	its general partner

	By:
	Name: Maurice Amsellem
	Title: Authorized Signatory

[Signatures Continue on Following Page]

MidCap / Keystone / Amendment No. 1 to Credit Agreement (Revolving Loan)


LENDERS:	MIDCAP FUNDING IV TRUST

	By:	Apollo Capital Management, L.P.,
		its investment manager

	By:	Apollo Capital Management GP, LLC,
		its general partner

		By:
		Name: Maurice Amsellem
		Title: Authorized Signatory

[Signatures Continue on Following Page]

MidCap / Keystone / Amendment No. 1 to Credit Agreement (Revolving Loan)

MidCap / Keystone / Amendment No. 1 to Credit Agreement (Revolving Loan)

Executed by IMPLANT SOLUTIONS PTY LTD

ACN 126 288 864 in accordance with section 127 of the

Corporations Act 2001 (Cth):



		Signature of Director						Signature of Director/Secretary


		Amnon Tamir						Michael Tuckman
		Name of Director						Name of Director/Secretary

Executed by IOS INNOVATIONS PTY LTD ACN

640 856 873 in accordance with section 127 of the

Corporations Act 2001 (Cth):



		Signature of Director						Signature of Director/Secretary


		Amnon Tamir						Michael Tuckman
		Name of Director						Name of Director/Secretary

MidCap / Keystone / Amendment No. 1 to Credit Agreement (Revolving Loan)

INTELLECTUAL PROPERTY (REGISTRATIONS AND APPLICATIONS)

Credit Party that is Owner of
IP

Name / Identifier of IP

Type of IP
(e.g., patent,
TM, ^©,
mask work)

Matterid

Patent Number

Filing Date

Expiration Date

Country

Status

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-0002001

7,249,949

2004-06-29

UNITED STATES

ISSUED

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-0002AT1

1763324

2005-06-23

AUSTRIA

ISSUED

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-0002AU1

2005267241

2005-06-23

AUSTRALIA

ISSUED

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-0002BE1

1763324

2005-06-23

BELGIUM

ISSUED

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-0002CA1

2562696

2005-06-23

CANADA

ISSUED

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-0002CH1

1763324

2005-06-23

SWITZERLAND

ISSUED

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-0002CN1

ZL200580016480.X

2005-06-23

CHINA

ISSUED

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-0002CN2

102512254 B

2005-06-23

CHINA

ISSUED

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-0002CO1

1374

2005-06-23

COLOMBIA

ISSUED

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-0002CZ1

1763324

2005-06-23

CZECH
REPUBLIC

ISSUED

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-0002DE1

1763324

2005-06-23

GERMANY

ISSUED

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-0002DK1

1763324

2005-06-23

DENMARK

ISSUED

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-0002EP1

1763324

2005-06-23

EUROPEAN
PATENT
CONVENTION

ISSUED

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-0002ES1

1763324

2005-06-23

SPAIN

ISSUED

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-0002FI1

1763324

2005-06-23

FINLAND

ISSUED

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-0002FR1

1763324

2005-06-23

FRANCE

ISSUED

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-0002GB1

1763324

2005-06-23

UNITED
KINGDOM

ISSUED

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-0002GR1

3071244.B2

2005-06-23

GREECE

ISSUED

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-0002HK1

HK1104447

2005-06-23

2007-09-04

HONG KONG

ISSUED

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-0002HU1

1763324

2005-06-23

HUNGARY

ISSUED

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-0002IE1

1763324

2005-06-23

IRELAND

ISSUED

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-0002IL1

178624

2005-06-23

ISRAEL

ISSUED

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-0002IT1

832021000098732

2005-06-23

ITALY

ISSUED

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-0002JP1

4886683

2005-06-23

JAPAN

ISSUED

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-0002KR1

10-1168454

2005-06-23

SOUTH KOREA

ISSUED

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-0002LU1

1763324

2005-06-23

LUXEMBOURG

ISSUED

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-
0002MC1

1763324

2005-06-23

MONACO

ISSUED

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-
0002MX1

255986

2005-06-23

MEXICO

ISSUED

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-0002NL1

1763324

2005-06-23

NETHERLANDS

ISSUED

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-0002PL1

1763324

2005-06-23

POLAND

ISSUED

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-0002PT1

1763324

2005-06-23

PORTUGAL

ISSUED

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-0002SG1

126168

2005-06-23

SINGAPORE

ISSUED

Keystone Dental, Inc.

CARRY AND DRIVE DEVICE AND METHOD FOR DENTAL IMPLANT AND/OR COMPONENTS THEREOF

Patent

29962-0005002

8,029,282

2007-09-14

2005-08-10

UNITED STATES

ISSUED

Keystone Dental, Inc.

CARRY AND DRIVE DEVICE AND METHOD FOR DENTAL IMPLANT AND/OR COMPONENTS THEREOF

Patent

29962-0005CA1

2615812

2006-07-31

CANADA

ISSUED

Keystone Dental, Inc.

CARRY AND DRIVE DEVICE AND METHOD FOR DENTAL IMPLANT AND/OR COMPONENTS THEREOF

Patent

29962-0005IL1

189412

2006-07-31

2008-02-10

ISRAEL

ISSUED

Keystone Dental, Inc.

CARRY AND DRIVE DEVICE AND METHOD FOR DENTAL IMPLANT AND/OR COMPONENTS THEREOF

Patent

29962-0005JP1

5094722

2006-07-31

JAPAN

ISSUED

Keystone Dental, Inc.

DENTAL IMPLANT

Patent

29962-0018001

D612,055

2007-04-23

UNITED STATES

ISSUED

Keystone Dental, Inc.

DENTAL IMPLANT

Patent

29962-0018EU1

000594601-0001

2006-09-25

EUROPEAN
UNION

ISSUED

Keystone Dental, Inc.

DENTAL IMPLANT

Patent

29962-0018EU2

000594601-0002

2006-09-25

EUROPEAN
UNION

ISSUED

Keystone Dental, Inc.

DENTAL IMPLANT

Patent

29962-0018EU3

000594601-0003

2006-09-25

EUROPEAN
UNION

ISSUED

Keystone Dental, Inc.

DENTAL IMPLANT

Patent

29962-0018GB1

90005946010001

2006-09-25

UNITED
KINGDOM

ISSUED

Keystone Dental, Inc.

DENTAL IMPLANT

Patent

29962-0018GB2

90005946010002

2006-09-25

UNITED
KINGDOM

ISSUED

Keystone Dental, Inc.

DENTAL IMPLANT

Patent

29962-0018GB3

90005946010003

2006-09-25

UNITED
KINGDOM

ISSUED

Keystone Dental, Inc.

DENTAL IMPLANT

Patent

29962-0018IT1

0000090314

2005-09-26

ITALY

ISSUED

Keystone Dental, Inc.

DENTAL IMPLANT

Patent

29962-0019EU1

000631601-0001

2006-12-01

EUROPEAN
UNION

ISSUED

Keystone Dental, Inc.

DENTAL IMPLANT

Patent

29962-0019EU2

000631601-0002

2006-12-01

EUROPEAN
UNION

ISSUED

Keystone Dental, Inc.

DENTAL IMPLANT

Patent

29962-0019GB1

90006316010001

2006-12-01

UNITED
KINGDOM

ISSUED

Keystone Dental, Inc.

DENTAL IMPLANT

Patent

29962-0019GB2

90006316010002

2006-12-01

UNITED
KINGDOM

ISSUED

Keystone Dental, Inc.

DENTAL IMPLANT

Patent

29962-0020EU1

000642145-0001

2006-12-21

EUROPEAN
UNION

ISSUED

Keystone Dental, Inc.

DENTAL IMPLANT

Patent

29962-0020EU2

000642145-0002

2006-12-21

EUROPEAN
UNION

ISSUED

Keystone Dental, Inc.

DENTAL IMPLANT

Patent

29962-0020GB1

90006421450001

2006-12-21

UNITED
KINGDOM

ISSUED

Keystone Dental, Inc.

DENTAL IMPLANT

Patent

29962-0020GB2

90006421450002

2006-12-21

UNITED
KINGDOM

ISSUED

Keystone Dental, Inc.

OSTEOINTEGRATIVE INTERFACE FOR IMPLANTABLE PROSTHESES AND A METHOD FOR THE TREATMENTOF THE OSTEOINTEGRATIVE INTERFACE

Patent

29962-0024DE1

60301796.7

2003-05-30

GERMANY

ISSUED

Keystone Dental, Inc.

IMPRESSION CAP

Patent

29962-0027001

7,163,398

2002-03-13

2022-03-13

UNITED STATES

EXPIRED

Keystone Dental, Inc.

IMPLANT-DRIVER ASSEMBLY

Patent

29962-0028001

7,887,325

2008-04-04

UNITED STATES

ISSUED

Keystone Dental, Inc.

urface Treatment For Metals, Particularly For Titanium, Alloys, Containing Titanium, Alloys Containing Titanium Oxides, For Medical, Surgical And Implantological Use

Patent

29962-0031EP1

2180083

2008-10-21

EUROPE

ISSUED

Keystone Dental, Inc.

SURFACE TREATMENT FOR TITANIUM, ALLOYS, CONTAINING TITANIUM, ALLOYS CONTAINING TITATNIUM OXIDES, FOR MEDICAL, SURGICAL AND IMPLANTOLOGICAL USE

Patent

29962-0031DE1

602008015841.1

2008-10-21

GERMANY

ISSUED

Keystone Dental, Inc.

SURFACE TREATMENT FOR TITANIUM, ALLOYS, CONTAINING TITANIUM, ALLOYS CONTAINING TITATNIUM OXIDES, FOR MEDICAL, SURGICAL AND IMPLANTOLOGICAL USE

Patent

29962-0031FR1

2180083

2008-10-21

FRANCE

ISSUED

Keystone Dental, Inc.

SURFACE TREATMENT FOR TITANIUM, ALLOYS, CONTAINING TITANIUM, ALLOYS CONTAINING TITATNIUM OXIDES, FOR MEDICAL, SURGICAL AND IMPLANTOLOGICAL USE

Patent

29962-0031GB1

2180083

2008-10-21

UNITED
KINGDOM

ISSUED

Keystone Dental, Inc.

SURFACE TREATMENT FOR TITANIUM, ALLOYS, CONTAINING TITANIUM, ALLOYS CONTAINING TITATNIUM OXIDES, FOR MEDICAL, SURGICAL AND IMPLANTOLOGICAL USE

Patent

29962-0031IT1

2180083

2008-10-21

ITALY

ISSUED

Keystone Dental, Inc.

DENTAL IMPLANT

Patent

29962-0033001

D612,055

2007-04-23

UNITED STATES

ISSUED

Keystone Dental, Inc.

INTERNAL CONNECTION DENTAL IMPLANT

Patent

29962-0002BR1

PI0509047-4

2005-06-23

BRAZIL

ISSUED

Implant Solutions Pty Ltd

Nexus Plus invention - A dental prosthesis

Patent

M53056082
(29962-
0094AU2)

2019101679

2019-11-07

2027-11-07

Australia
(Innovation
Patent)

Granted

Implant Solutions Pty Ltd

Scan gauge invention - Apparatus for facilitating acquisition of a scan and an intraoral scanning procedure

Patent

M53095602
(29962-
0091AU1)

2020102538
(Innovation Patent)

2020-09-30

2028-09-30

Australia

Granted

Implant Solutions Pty Ltd

Scan gauge invention - Design Protection - Intraoral scan body

Patent

M53097500
(29962-
0096AU1)

202015430

2020-10-02

2030-10-02

Australia

Granted

Implant Solutions Pty Ltd

Scan gauge invention - Design Protection - Dental instruments

Patent

M53122213
(29962-
0096EU1)

008484836-0001

2021-04-01

2026-04-01

European
Community
(EUIPO)

Granted

Implant Solutions Pty Ltd

Scan gauge invention - Design Protection - Intraoral scan body

Patent

M53122226
(29962-
0096HK1)

2117803.7

2021-04-01

2046-04-01

Hong Kong

Granted

Implant Solutions Pty Ltd

Scan gauge invention - Design Protection - Intraoral scan body

Patent

M53122252
(29962-
0096GB1)

6127816

2021-04-01

2046-03-31

United Kingdom

Granted

Implant Solutions Pty Ltd

Nexus Plus invention - A dental prosthesis

Patent

M53053547
(29962-
0094TW1)

108140464

2019-11-07

No estimate
provided by
Derwent or
PatSnap

Taiwan

Pending

Implant Solutions Pty Ltd

Nexus Plus invention - A dental prosthesis

Patent

M53119132
(29962-
0094AU1)

2019317632

2019-11-07

No estimate
provided by
Derwent or
PatSnap

Australia

Pending

Implant Solutions Pty Ltd

Nexus Plus invention - A dental prosthesis

Patent

M53119145
(29962-
0094EP1)

19848244

2019-11-07

No estimate
provided by
Derwent or
PatSnap

European Patent
Convention

Pending

Implant Solutions Pty Ltd

Nexus Plus invention - A dental prosthesis

Patent

M53119158
(29962-
0094JP1)

2021-520310

2019-11-07

PatSnap
provides no
estimated
expiration date
for
AU2018904243

Japan

Pending

Implant Solutions Pty Ltd

Nexus Plus invention - A dental prosthesis

Patent

M53119171
(29962-
0094NZ1)

774413

2019-11-07

PatSnap
provides no
estimated
expiration date
for
AU2018904243

New Zealand

Pending

Implant Solutions Pty Ltd

Nexus Plus invention - A dental prosthesis

Patent

M53119184
(29962-
0094US1)

17/286706

2019-11-07

No estimate
provided by
Derwent or
PatSnap

United States of
America

Pending

Implant Solutions Pty Ltd

Dental Jig invention - Denture preparation assembly, method and apparatus

Patent

M53140283
(29962-
0095AU1)

2020232981

2020-03-06

No estimate
provided by
Derwent or
PatSnap

Australia

Pending

Implant Solutions Pty Ltd

Dental Jig invention - Denture preparation assembly, method and apparatus

Patent

M53140296
(29962-
0095EP1)

20766705.6

2020-03-06

EP3934565
(not yet
published –
European
Patent Register
link)

Europe

Pending

Implant Solutions Pty Ltd

Dental Jig invention - Denture preparation assembly, method and apparatus

Patent

M53140309
(29962-
0095JP1)

2021-547840

2020-03-06

Not listed in the
JPO’s site yet

Japan

Pending

Implant Solutions Pty Ltd

Dental Jig invention - Denture preparation assembly, method and apparatus

Patent

M53140322
(29962-
0095NZ1)

779047

2020-03-06

NZ779047
(National Phase
entry of PCT –
link here)

New Zealand

Pending

Implant Solutions Pty Ltd

Dental Jig invention - Denture preparation assembly, method and apparatus

Patent

M53140335
(29962-
0095US1)

17/433457

2020-03-06

Unable to
locate in
Derwent,
PatSnap or
USPTO Public
Pair

United States of
America

Pending

Implant Solutions Pty Ltd

Scan gauge invention - Apparatus for facilitating acquisition of a scan and an intraoral scanning procedure

Patent

M53101010
(29962-
0091TW)

109138152

2020-11-03

PatSnap
provides no
estimated
expiration date
for AU
2019904154

Taiwan

Pending

Implant Solutions Pty Ltd

Scan gauge invention - Design Protection - Intraoral scan body

Patent

M53122239
(20443-
0096001)

29/776891

2021-04-01

Design Patent
Application
Number – not
available in
public PAIR
yet

United States of
America

Pending

Implant Solutions Pty Ltd

Scan gauge invention - Design Protection - Intraoral scan body

Patent

M53122265
(20443-
0096JP1)

2021-006954

2021-04-01

2046-04-01

Japan

Pending

Paltop Advanced Dental Solutions Ltd

Dental Implant

Patent

15/440,462

8731310,987,201

2017-02-23

United States of
America

Issued

Paltop Advanced Dental Solutions Ltd

Implant Placement Key

Patent

15/906,081

8972510,792,132

2018-02-27

United States of
America

Issued

Paltop Advanced Dental Solutions Ltd

Drilling Guide

Patent

16/020,332

9003810,987,196

2018-06-27

United States of
America

Issued

Keystone Dental, Inc.

KEY-PLAN

Trademark

2087999

2021-03-26

Pending

Keystone Dental, Inc.

KEY-PLAN

Trademark

18415847

2021-03-03

2031-03-03

Registered

Keystone Dental, Inc.

GENESIS

Trademark

35478532

2018-12-21

Abandoned

Keystone Dental, Inc.

MOLARIS

Trademark

90/655735

2021-04-19

2028-02-02

Registered

Keystone Dental, Inc.

I-HEXMRT

Trademark

1957785

2019-04-17

Pending

Keystone Dental, Inc.

GENESIS

Trademark

17917568

2018-06-14

2028-06-14

Registered

Keystone Dental, Inc.

GENESIS

Trademark

32077040

2018-07-05

Abandoned

Keystone Dental, Inc.

GENESIS

Trademark

3697685

2021-09-20

2031-09-20

Registered

Keystone Dental, Inc.

DYNACORE

Trademark

1929267

2018-11-07

2031-11-23

Registered

Keystone Dental, Inc.

TI-LOBE TITE

Trademark

88/698026

2019-11-19

26-07-2027

Registered

Keystone Dental, Inc.

K-LEAN

Trademark

88/712316

2019-12-02

Pending

Keystone Dental, Inc.

WE FOLLOW SCIENCE

Trademark

88/712318

2019-12-02

Pending

Keystone Dental, Inc.

DIVA

Trademark

2001172

2019-12-13

Pending

Keystone Dental, Inc.

DIVA

Trademark

88/725261

2019-12-12

Pending

Keystone Dental, Inc.

GENESIS THE BIOMIMETIC IMPLANT SYSTEM

Trademark

77/949640

2010-03-03

2032-01-31

Registered

Keystone Dental, Inc.

BIOSPARK

Trademark

9222929

2011-03-17

2022-04-14

Abandoned

Keystone Dental, Inc.

STAGE-1

Trademark

2814127

2002-08-14

2022-08-14

Abandoned

Keystone Dental, Inc.

STAGE-1

Trademark

50107/2002

2002-08-15

2022-08-15

Abandoned

Keystone Dental, Inc.

ANATITE

Trademark

40-2011-0012891

2011-03-14

2022-08-24

Abandoned

Keystone Dental, Inc.

BIOSPARK

Trademark

40-2011-0013195

2011-03-15

2022-08-24

Abandoned

Keystone Dental, Inc.

CALFORMA

Trademark

1250328

2005-03-11

2022-10-18

Abandoned

Keystone Dental, Inc.

SMARTER THINKING. SIMPLER DESIGN

Trademark

85/444120

2011-10-11

2023-01-08

Registered

Keystone Dental, Inc.

STAGE-1

Trademark

585335

2003-01-27

2023-01-27

Registered

Keystone Dental, Inc.

TILOBEMAXX

Trademark

86/924908

2016-03-01

2023-05-21

Registered

Keystone Dental, Inc.

PRIMASOLO

Trademark

1259438

2005-05-31

2023-10-24

Registered

Keystone Dental, Inc.

PRIMACONNEX

Trademark

1259439

2005-05-31

2023-11-04

Registered

Keystone Dental, Inc.

PALTOP

Trademark

87/570958

2017-08-16

2023-11-13

Registered

Keystone Dental, Inc.

GENESIS THE BIOMIMETIC IMPLANT SYSTEM & DESIGN

Trademark

85/154709

2010-10-18

2023-11-19

Registered

Keystone Dental, Inc.

KEYSTONE

Trademark

87/361863

2017-03-07

2023-05-29

Registered

Keystone Dental, Inc.

PRIMA PLUS

Trademark

87/863775

2018-04-04

2024-02-21

Registered

Keystone Dental, Inc.

GENESIS

Trademark

87/761042

2018-01-18

2023-02-21

Registered

Keystone Dental, Inc.

RESTORE

Trademark

197563

1994-04-28

2024-04-28

Registered

Keystone Dental, Inc.

PRIMA

Trademark

87/446220

2017-05-11

2024-04-30

Registered

Keystone Dental, Inc.

RESTORE

Trademark

RM1994C002159

1994-05-16

2024-05-16

Registered

Keystone Dental, Inc.

BIOSPARK

Trademark

85/131895

2010-09-17

2024-05-27

Registered

Keystone Dental, Inc.

ANATITE

Trademark

85/131880

2010-09-17

2024-05-27

Registered

Keystone Dental, Inc.

SUPERCAT

Trademark

3364792

2002-11-11

2024-08-21

Registered

Keystone Dental, Inc.

RESTORE

Trademark

74/471499

1993-12-16

2024-12-27

Registered

Keystone Dental, Inc.

DYNACORE

Trademark

88/190786

2018-11-12

2025-04-08

Registered

Keystone Dental, Inc.

PRIMASOLO

Trademark

4466521

2005-06-01

2025-06-01

Registered

Keystone Dental, Inc.

PRIMACONNEX

Trademark

4466538

2005-06-01

2025-06-01

Registered

Keystone Dental, Inc.

TILOBE

Trademark

1336453

2007-02-22

2025-06-21

Registered

Keystone Dental, Inc.

RESTORE

Trademark

40-1994-0021402

1994-05-30

2026-01-16

Registered

Keystone Dental, Inc.

I-HEXMRT

Trademark

88/387869

2019-04-16

2026-06-08

Registered

Keystone Dental, Inc.

PRIMACONNEX

Trademark

78/531583

2004-12-13

2026-09-05

Registered

Keystone Dental, Inc.

PRIMASOLO

Trademark

78/531560

2004-12-13

2026-09-05

Registered

Keystone Dental, Inc.

TILOBE

Trademark

5704002

2007-02-21

2027-02-21

Registered

Keystone Dental, Inc.

TILOBE

Trademark

838429

2007-02-23

2027-02-23

Registered

Keystone Dental, Inc.

RESTORE

Trademark

274576

1994-05-18

2027-06-23

Registered

Keystone Dental, Inc.

TILOBE

Trademark

2007-015603

2007-02-23

2027-07-06

Registered

Keystone Dental, Inc.

TILOBE

Trademark

96008889

2007-02-27

2027-11-30

Registered

Keystone Dental, Inc.

TILOBE

Trademark

40-2007-0010379

2007-02-23

2027-12-17

Registered

Keystone Dental, Inc.

GENESIS

Trademark

74150/2018

2018-06-04

2028-06-04

Registered

Keystone Dental, Inc.

TILOBE

Trademark

764039

2007-02-26

2028-07-10

Registered

Keystone Dental, Inc.

TILOBE

Trademark

78/964909

2006-08-31

2028-12-09

Registered

Keystone Dental, Inc.

DYNAMATRIX

Trademark

77/470114

2008-05-09

2029-09-08

Registered

Keystone Dental, Inc.

GENESIS

Trademark

884703

1998-07-16

2029-10-28

Registered

Keystone Dental, Inc.

GENESIS

Trademark

2019/117377

2019-11-25

2029-11-25

Registered

Keystone Dental, Inc.

Genesis The Biomimetic Implant System & design

Trademark

9045097

2010-04-21

2030-04-21

Registered

Keystone Dental, Inc.

GENESIS THE BIOMIMETIC IMPLANT SYSTEM

Trademark

1983943

2019-09-06

2030-09-23

Registered

Keystone Dental, Inc.

GENESIS

Trademark

1900450

2018-05-23

2030-12-15

Registered

Keystone Dental, Inc.

PALTOP

Trademark

236203

2011-03-03

2031-03-03

Registered

Keystone Dental, Inc.

ANATITE

Trademark

9802562

2011-03-11

2031-03-10

Registered

Keystone Dental, Inc.

ANATITE

Trademark

9802562

2011-03-11

2031-03-11

Registered

Keystone Dental, Inc.

BIOSPARK

Trademark

9808247

2011-03-14

2031-03-13

Registered

Keystone Dental, Inc.

BIOSPARK

Trademark

9808247

2011-03-14

2031-03-14

Registered

Keystone Dental, Inc.

TILOBEMAXX

Trademark

1788789

2016-06-27

2032-11-10

Registered

Keystone Dental, Inc.

BIOSPARK

Trademark

909808247

2011-03-14

2031-03-14

Registered

Keystone Dental, Inc.

GENESIS THE BIOMIMETIC IMPLANT SYSTEM

Trademark

909045097

2010-04-21

2030-04-21

Registered

Keystone Dental, Inc.

PRIMACONNEX

Trademark

904466538

2005-06-01

2025-06-01

Registered

Keystone Dental, Inc.

PRIMASOLO

Trademark

904466521

2005-06-01

2025-06-01

Registered

Keystone Dental, Inc.

STAGE-1

Trademark

902814127

2002-08-14

Abandoned

Keystone Dental, Inc.

TILOBE

Trademark

905704002

2007-02-21

2027-02-21

Registered

Keystone Dental, Inc.

QUICK-CAP

Trademark

76425572

2002-06-25

Registered

Keystone Dental, Inc.

RESTORE

Trademark

902255686

2014-04-23

2024-04-23

Registered

Keystone Dental, Inc.

DYNAFIBER

Trademark

2022-02-07

Pending

Keystone Dental, Inc.

GENESIS ACTIVE

Trademark

2022-11-22

Pending

Keystone Dental, Inc.

DYNAFIBER

Trademark

97252730

2022-02-03

U.S.

Pending

Implant Solutions Pty Ltd

Biaxial

ORG
(Trademark)

1933584

2018-06-13

Australia

Registered

Implant Solutions Pty Ltd

Just in Time

ORG
(Trademark)

2130594

2020-10-30

Australia

Registered

Implant Solutions Pty Ltd

NEXUS

ORG
(Trademark)

2251183

2022-03-02

Australia

Pending

Implant Solutions Pty Ltd

Nexus iOS

DIV
(Trademark)

2182200

2020-10-08

Australia

Registered

Implant Solutions Pty Ltd

Nexus iOS

ORG
(Trademark)

2126993

2020-10-08

Australia

Accepted

Implant Solutions Pty Ltd

Nexus iOS (Logo)

Trademark

Australia

Pending

Implant Solutions Pty Ltd

Nexus iOS (Logo)

Trademark

Australia

Pending

Implant Solutions Pty Ltd

Nexus iOS (Logo)

Trademark

Australia

Pending

Implant Solutions Pty Ltd

Nexus Suprastructures

ORG
(Trademark)

2126998

2020-10-08

Australia

Accepted

Implant Solutions Pty Ltd

Nexus Suprastructures

DIV
(Trademark)

2182197

2020-10-08

Australia

Registered

Implant Solutions Pty Ltd

Osteon Medical Logo

ORG
(Trademark)

1933583

2018-06-13

Australia

Registered

Implant Solutions Pty Ltd

Overlapping Triangle Logo

ORG
(Trademark)

2275290

2022-06-15

Australia

Accepted

Implant Solutions Pty Ltd

Biaxial

PROT
(Trademark)

1598224

2021-05-27

China

Registered

Implant Solutions Pty Ltd

Just in Time

Trademark

China

Pending

Implant Solutions Pty Ltd

Just in Time

Trademark

China

Pending

Implant Solutions Pty Ltd

Osteon Medical Logo

Trademark

China

Pending

Implant Solutions Pty Ltd

Osteon Medical Logo

Trademark

China

Pending

Implant Solutions Pty Ltd

Osteon Medical Logo

Trademark

China

Pending

Implant Solutions Pty Ltd

Biaxial

PROT
(Trademark)

1598224

2021-05-27

European Union

Registered

Implant Solutions Pty Ltd

Just in Time

PROT
(Trademark)

1597936

2021-05-27

European Union

Registered

Implant Solutions Pty Ltd

NEXUS

PROT
(Trademark)

1684234

2022-08-17

European Union

Accepted

Implant Solutions Pty Ltd

Nexus iOS

PROT
(Trademark)

1603615

2021-06-30

European Union

Registered

Implant Solutions Pty Ltd

Nexus Suprastructures

PROT
(Trademark)

1603679

2021-06-30

European Union

Registered

Implant Solutions Pty Ltd

Osteon Medical Logo

PROT
(Trademark)

1599778

2021-05-27

European Union

Registered

Implant Solutions Pty Ltd

Overlapping Triangle logo

PROT
(Trademark)

1678016

2022-07-05

European Union

Accepted

Implant Solutions Pty Ltd

Biaxial

ORG
(Trademark)

1598224

2021-05-27

International
Bureau (WIPO)

Registered

Implant Solutions Pty Ltd

Just in Time

ORG
(Trademark)

1597936

2021-05-27

International
Bureau (WIPO)

Registered

Implant Solutions Pty Ltd

NEXUS

ORG
(Trademark)

1684234

2022-08-17

2022-03-02

International
Bureau (WIPO)

Registered

Implant Solutions Pty Ltd

Nexus iOS

ORG
(Trademark)

1603615

2021-06-30

International
Bureau (WIPO)

Registered

Implant Solutions Pty Ltd

Nexus Suprastructures

ORG
(Trademark)

1603679

2021-06-30

International
Bureau (WIPO)

Registered

Implant Solutions Pty Ltd

Osteon Medical Logo

ORG
(Trademark)

1599778

2021-05-27

International
Bureau (WIPO)

Registered

Implant Solutions Pty Ltd

Overlapping Triangle Logo

ORG
(Trademark)

1678699

2022-07-20

International
Bureau (WIPO)

Pending

Implant Solutions Pty Ltd

Overlapping Triangle logo

ORG
(Trademark)

1678016

2022-07-05

International
Bureau (WIPO)

Registered

Implant Solutions Pty Ltd

Biaxial

PROT
(Trademark)

1182226

2021-05-27

New Zealand

Registered

Implant Solutions Pty Ltd

Just in Time

PROT
(Trademark)

1182148

2021-05-27

New Zealand

Registered

Implant Solutions Pty Ltd

NEXUS

PROT
(Trademark)

1220044

2022-08-17

New Zealand

Pending

Implant Solutions Pty Ltd

Nexus iOS

PROT
(Trademark)

1184858

2021-06-30

New Zealand

Registered

Implant Solutions Pty Ltd

Nexus Suprastructures

PROT
(Trademark)

1184779

2021-06-30

New Zealand

Registered

Implant Solutions Pty Ltd

Osteon Medical Logo

PROT
(Trademark)

1182890

2021-05-27

New Zealand

Registered

Implant Solutions Pty Ltd

Overlapping Triangle logo

PROT
(Trademark)

1217381

2022-07-05

New Zealand

Pending

Implant Solutions Pty Ltd

Biaxial

PROT
(Trademark)

1598224

2021-05-27

2021-11-11

United Kingdom

Registered

Implant Solutions Pty Ltd

Just in Time

PROT
(Trademark)

WO0000001597936

2021-05-27

United Kingdom

Registered

Implant Solutions Pty Ltd

NEXUS

PROT
(Trademark)

1684234

2022-08-17

United Kingdom

Pending

Implant Solutions Pty Ltd

Nexus iOS

PROT
(Trademark)

1603615

2021-06-30

United Kingdom

Registered

Implant Solutions Pty Ltd

Nexus Suprastructures

PROT
(Trademark)

1603679

2021-06-30

United Kingdom

Registered

Implant Solutions Pty Ltd

Osteon Medical Logo

PROT
(Trademark)

1599778

2021-05-27

United Kingdom

Registered

Implant Solutions Pty Ltd

Overlapping Triangle logo

PROT
(Trademark)

1678016

2022-07-05

United Kingdom

Registered

Implant Solutions Pty Ltd

Biaxial

PROT
(Trademark)

79313879

2021-05-27

United States of
America

Accepted

Implant Solutions Pty Ltd

Just in Time

PROT
(Trademark)

79313779

2021-05-27

United States of
America

Registered

Implant Solutions Pty Ltd

NEXUS

PROT
(Trademark)

79350164

2022-08-17

United States of
America

Pending

Implant Solutions Pty Ltd

Nexus iOS

PROT
(Trademark)

79316234

2021-06-30

United States of
America

Registered

Implant Solutions Pty Ltd

Nexus iOS

PROT
(Trademark)

90736553

2021-05-26

United States of
America

Allowed

Implant Solutions Pty Ltd

Nexus Suprastructures

PROT
(Trademark)

79316255

2021-06-30

United States of
America

Registered

Implant Solutions Pty Ltd

NEXUS SUPRASTRUCTURES

PROT
(Trademark)

90736537

2021-05-26

United States of
America

Allowed

Implant Solutions Pty Ltd

Osteon Medical Logo

PROT
(Trademark)

79314551

2021-05-27

United States of
America

Accepted

Implant Solutions Pty Ltd

Overlapping Triangle logo

PROT
(Trademark)

79347498

2022-07-05

United States of
America

Pending

Implant Solutions Pty Ltd

NEXUS IOS INNOVATIVE IOS TECHNOLOGIES

Trademark

2126996

Australia

Pending

Schedule 5.14 — Deposit Accounts and Securities Accounts

[***]

Schedule 9.2(b) – Collateral Information

Filing Offices


Keystone Dental Holdings, Inc.		- Secretary of State of the State of Delaware

Keystone Dental, Inc.		- Secretary of State of the State of Delaware

US IP Collateral		- United States Patent and Trademark Office

Registered Office and Principal Place of Business of Each Loan Party and its Subsidiaries

Keystone Dental Holdings, Inc.

154 Middlesex Turnpike

Burlington, MA 01803

Keystone Dental Inc.

154 Middlesex Turnpike

Burlington, MA 01803

Southern Implants, Inc. (dormant)

154 Middlesex Turnpike

Burlington, MA 01803

SBT Dental LLC (dormant)

154 Middlesex Turnpike

Burlington, MA 01803

Paltop USA, Inc

154 Middlesex Turnpike

Burlington, MA 01803

Paltop Advanced Dental Solutions, Ltd.

Hashita 5 Caesarea

Caesarea Israel

Implant Solutions Pty Ltd (trading as Osteon Medical)

759-767 Springvale Road, Mulgrave, Victoria, 3170,

Australia

IOS Innovations Pty Ltd

759-767 Springvale Road, Mulgrave, Victoria, 3170,

Australia

Osteon Digital Japan [Co., Ltd].

3-5-4 Nagayoshi Kawanabe, Hirano-ku, Osaka-shi,

Osaka, Japan

Osteon Medical Europe SAS

11 Rue Des Aulnes – 69410 Champagne Au Mont

D’Or, France

Locations of Collateral and Books and Records

Leased business location operated by Credit Parties

154 Middlesex Turnpike

Burlington, MA 01803

Leased business location operated by Credit Parties

13645 Alton Parkway, Unit A

Irvine, CA 92618

Leased business location operated by Credit Parties

175 Technology Drive, Suite 175

Irvine, CA 92618

Leased business location operated by Credit Parties

Hashita 5 Caesarea

Caesarea Israel

Leased business location operated by Credit Parties

759-767 Springvale Road, Mulgrave, Victoria, 3170,

Australia

Schedule 9.2(d) – Chattel Paper, Letter of Credit Rights, Commercial Tort Claims, Instruments, Documents, Investment Property

None.